Characterization of polymer/drug films as models for
Transcription
Characterization of polymer/drug films as models for
Polymer/drug films as a model system for a drug eluting coronary stent coating layer Valeria Ciarnelli Prof. Clive Roberts Prof. Morgan Alexander, Prof. Martyn Davies School of Pharmacy The University of Nottingham 14 September 2012 PharmSci_APS Introduction: what is a coronary stent? The coronary artery stent is a tubular device, in the form of a coil or mesh, that is inserted at the site of arterial obstruction via a catheter. This device widens the coronary artery improving blood flow to the ischemic heart muscle. 2 types: Bare metal stent (BMS) Drug eluting stent (DES) A Obstruction: plaque. The stent is placed via catheter B Balloon inflated The artery is expanded C Scaffolding action The blood flow is re-established Targets Drug eluting stent + Drug/Polymer coating layer Characterization of films as models for drug eluting coronary stent coating layer Characterization of the actual drug eluting coronary stent coating layer This work is a part of analytical support to develop a medical device Optimization of manufactoring process Methods. Spun cast film preparation and equipments used Spin casting Spray coating AFM (XPS) 3 (ToF-SIMS) Spun cast or spray coated film Sample ID Series 1* Series 2* Casting Procedure Spun cast Spun cast Drying Step Room condition Bake in oven (50°C for 45 min) Series 3* Spray coated Warm air (50°C for 15 sec each 2nd spray cycle) Series 4* Spun cast in argon atmosphere Bake in oven (50°C for 45 min under vacuum) *The films were made from solutions at different drug polymer weigh ratio precisely at 1:3; 1:1 and 3:1. Pure polymer and drug films were also made as references models. Methods. Atomic Force Microscopy (AFM) A) Ball and stick model of pentacene B) STM images, C) and D) NC-AFM image of pentacene A 5Å C 5Å 1.3 Å B 5Å - 2 Hz - 7 Hz 0Å + 1 Hz D 20 Å Leo Gross et al, Science, 2009 Leo Gross et al, Science, 2009, 324, 1428 - 5 Hz Methods. Time of flight Secondary Ion Mass Spectroscopy (ToF-SIMS) Sputter Ion Beam Analysis Ion Beam 100 µm 300 µm y x Intensity Depth z Anna Belu et al. Chemical imaging of drug eluting coatings: Combining surface analysis and confocal Raman microscopy Methods. X-Ray Photo-electron Spectroscopy (XPS) Photoemission peak Photo emission Inelastic scattering tail Free electron X-rays X-Ray Valence electrons eV Core electrons Nucleus X-Ray Coronene Molecule (C24H12) Results. AFM characterization. Series 1 and 2 Series 1. Spun cast film without heating step. Tapping mode. Topography Topography Phase 220nm 63° 0 nm - 90° 1 µm Topography Phase 134nm 60° 0 nm - 90° 2 µm 1 µm 0 nm 1:3 d:p wr Phase 41° 150nm - 90° 1: 1 d:p wr 3: 1 d:p wr Increasing drug loading • Film at 1:3 wr shows circular pit features (diameter approximately 10 - 250 nm). Clear evidence of phase separation • Film at 3:1 drug polymer weight ratio shows globular surface features Series 2. Spun cast film with heating step (50°C for 45 min). QNM mode. Topography Topography DMT modulus 330nm Topography DMT modulus 200 nm 250 MPa DMT modulus 145 nm 137 MPa 3 GPa c 2 µm 1 µm 0 nm 1:3 d:p wr 0 MPa 1 µm 0 nm 1: 1 d:p wr 0 MPa 0 nm 0 GPa 3: 1 d:p wr • Film at 1:1 shows network structure surrounding deeper areas, globular features with a diameter of approximately 100 nm Results. AFM characterization. Series 2 and 3 Series 3. Spray coated film on silicon wafer with heating step. (QNM mode) 167 nm Topography 1 µm DMT modulus 5.8 GPa 551 nm Topography DMT modulus 2.6 GPa 1 µm 0 nm 1 GPa DMT modulus 1 µm 2.4 GPa 0 nm 1:3 d:p wr 216 nm Topography 0 nm 0 GPa 1: 1 d:p wr 75 MPa 3: 1 d:p wr Increasing drug loading • Presence of globular features (diameter ≈ 100 nm) showing mechanical heterogeneity • Features organized in globular domains also observed in the spun cast films. • These features occur at a higher incidence with increasing drug concentration Series 4. Spun cast film on silicon prepared in argon atmosphere with heating step (50°C for 45 min) under vacuum. ( tapping mode RH = 5%) Topography 2 nm Phase 120° 1 µm Topography 8 nm Phase -15° 1:3 d:p wr 100° 33 nm -15° Phase 1 µm 2µm 0 nm Topography 0 nm 1: 1 d:p wr -27° 0 nm 3: 1 d:p wr • Different morphology although still presence of globular domains with diameter ranging from 100 nm to 350 nm -21° Results. ToF-SIMS characterization. Depth profiling of spun cast films series 1 Series 1. Spun cast film on silicon wafer 1:3 d:p weight ratio Bulk 14000 9000 Film at 1:1 drug polymer weight ratio without heating step 18000 Polymer PLA Interface Drug 12000 Everolimus Intensity (ion count) Intensity (ion count) 20000 Film at 1:3 drug polymer weight ratio without heating step 3:1 d:p weight ratio Silicon x 5 10000 8000 6000 4000 16000 Polymer PLA 14000 Drug Everolimus Silicon x 10 12000 10000 8000 6000 Everolimus Drug 6000 4000 3000 2000 2000 1000 0 0 Surface 200 Depht (nm) 300 400 500 Silicon x 5 5000 4000 100 PLA Polymer 7000 2000 0 Film at 3:1 drug polymer weight ratio without heating step 8000 Intensity (ion count) 16000 1:1 d:p weight ratio 0 0 100 200 300 400 500 0 100 Depht (nm) Drug Polymer 200 300 Depht (nm) 400 500 600 Silicon x n (n= 5,10 and 5 for 1:3, 1:1 and 3:1 respectively) • This indicates that the drug migrates to the surface and to an extent at the substrate interface leaving the polymer relatively concentrated in the bulk. • Overall relative ion peak intensities for drug and polymer markers are consistent with the respective concentration Sputter time (sec) 277 Sputter rate (nm/sec) 0.90 Sample ID Thickness (nm) 1:3 d:p wr 250 1:1 d:p wr 315 351 0.90 3:1 d:p wr 288 342 0.85 Results. ToF-SIMS characterization. Depth profiling of spun cast films series 2 Series 2. Spun cast film on glass slide. The films underwent a drying step in the oven at 50°C for 45 min 1:3 d:p weight ratio 1:1 d:p weight ratio 60000 90000 70000 Film at 1:1 drug polymer weight ratio with heating step Film at 1:3 drug polymer weight ratio with heating step 80000 Polymer PLA Silicon Drug Everolimus 50000 40000 30000 50000 Polymer PLA 40000 Intensity (ion(ions) count) Counts Silicon 60000 Count (ions) 70000 Film at 3:1 drug polymer weight ratio with heating step 60000 50000 Intensity (ion count) Counts (ions) Intensity (ion count) 3:1 d:p weight ratio Drug Everolimus 30000 20000 Silicon 40000 Polymer PLA Drug Everolimus 30000 20000 20000 10000 10000 10000 0 0 0 50 100 150 200 250 300 0 0 Depth (nm) Polymer Drug The drug migrates to the surface forming a surface-enriched drug region for all the films at different loadings Polymer The polymer is concentrated in the bulk region of the film 1:1 d:p wr 50 100 150 Depth (nm) 200 250 Drug 300 350 0 50 Silicon 100 150 200 Depth (nm) 250 300 350 Results. ToF-SIMS characterization. Depth profiling of spun cast films series 3 Series 3. Spray coated film on silicon. The films underwent a drying step (warm air 50°C) 1:3 d:p weight ratio 200000 1:1 d:p weight ratio 70000 Spray coated film at 1:3 drug polymer wr. 180000 40000 Spray coated film at 1:1drug polymer wr Silicon 120000 Polymer 100000 Drug Intensity (ion count) Silicon 80000 60000 40000 50000 Polymer 40000 Drug Intensity (ion count) Silicon x 5 140000 30000 20000 10000 20000 0 500 1000 1500 Depth (nm) 2000 Drug Polymer Polymer The drug surface enrichment is less pronounced than the one observed for the spun cast films 1:1 d:p wr Polymer 25000 Drug 20000 15000 10000 0 0 2500 30000 5000 0 0 Spray coated film at 3:1 drug polymer wr 35000 60000 160000 Intensity (ion count) 3:1 d:p weight ratio 500 1000 1500 Depth (nm) 2000 Drug 2500 3000 0 1000 Silicon 2000 Depth (nm) 3000 4000 Results. XPS characterization. Surface analysis of spun cast films series 2 and spray coated films series 3 XPS spectra of drug powder 2 O 1s 80 3 O 1s x 10 25 C 1s x 10 XPS spectra of polymer powder 70 20 60 CPS 15 40 C 1s CPS 50 10 30 N 1s 20 5 10 0 0 1200 900 600 Bi ndi ng E nerg y (eV) 30 0 1 200 0 C Spun cast films (series 2) S ( hi i b 9 00 di di C S / i 6 00 Bi ndi ng E n ergy (eV) ) Spray coated films (series 3) 3 00 0 Spun cast films (series 4) 1:3 (25%) 1:1 (50%) 3:1 (75%) 1:3 (25%) 1:1 (50%) 3:1 (75%) 1:3 (25%) 1:1 (50%) 3:1 (75%) 0.37 0.74 1.1 0.37 0.74 1.1 0.37 0.74 1.1 N % (experimental) ± SD 1.3 ± 0.02 1.2 ± 0.04 1.1 ± 0.01 0.4 ± 0.04 1.0 ± 0.10 1.3 ± 0.05 1.29 ± 0.06 1.44 ± 0.04 1.39 ± 0.03 Experimental Drug % (w/w) ± SD 85.4 ± 1.0 83.3 ± 2.4 76.4 ± 0.7 27.2 ± 2.7 64.7 ± 7.0 88.5 ± 0.2 88.5 ± 4.0 Drug/polymer wr (Drug loading) N % (theoretical) Drug enrichment Less pronounced drug enrichment 99.5± 2.4 96.3± 1.7 Results. XPS characterization. Depth profiling of spun cast films: series 4 Series 4. Spun cast film on silicon. 50ºC for 45 min, Ar atmosphere and controlled humidity 1:1 d:p weight ratio 3:1 d:p weight ratio 1.6 80 1.4 70 1.6 70 1.2 1.2 50 1 40 0.8 30 0.6 20 10 0 50 100 Depth (nm) 0.2 10 C 1s Drug enrichment at the surface and interface (film/silicon). The same is observed for the other drug polymer concentrations. 0.6 30 20 150 0.8 40 0.4 1.2 1.2 70 70 1 50 0.4 0 0 60 1.4 1.4 80 80 N1s % 1.4 60 90 90 11 60 60 50 50 0.8 0.8 40 40 0.6 0.6 N1s % % N1s 90 1.8 C1s, & Si2p Si2p % % C1s, O1s O1s & 2 80 C1s, O1s & Si2p % 90 N1s % C1s, O1s & Si2p % 1:3 d:p weight ratio 30 30 0.4 0.4 20 20 0.2 0 0 0 20 40 O 1s 60 Depth (nm) 80 100 N 1s 120 0.2 0.2 10 10 00 00 00 50 50 100 150 100 150 Etching Etching time time(sec) (sec) Si 2p The drug profiles obtained from XPS and ToF-SIMS depth profiling are consistent. 200 200 Conclusions 9We are able to characterize this particular drug polymer coating layer using complementary surface analysis techniques. 9AFM shows the presence of globular features (diameter 100-150 nm) occurring at higher incidence with increased drug loading 9ToF-SIMS depth profiling on the model films showed the drug and polymer distribution as a function of depth, with the drug preferentially located at the surface 9The XPS analysis confirmed the existence of an enrichment of drug on the surface of the model films (series 2 and 3) at higher percentage compared to the bulk drug loading. In the case of the spray coated films the drug at the surface increased with the drug loading 9 The drug enrichment is more pronounced in the spun cast films than the spray coated films. 9We have gained an understanding of the distribution of the drug Acknowledgements Supervisors Prof Clive J Roberts Prof Morgan R Alexander Prof Martyn C Davies Thanks to: Prof Chen Xinyong Dr David J Scurr Mrs Emily Smith From Kratos Analytical Chris Blomfield Simon Hutton THANKS FOR LISTENING Results. ToF-SIMS Depth profiling of spun cast films: series 4 Series 4. Spun cast film on silicon wafer. Silicon substrate, 50 ºC for 45 min, Ar atmosphere and controlled humidity 1:3 d:p weight ratio 1:1 d:p weight ratio 60000 50000 40000 45000 35000 Silicon 40000 Polymer Drug 30000 20000 35000 Silicon 30000 Polymer 25000 Drug Intensity (ion count) 40000 Intensity (ion count) Intensity (ion count) 50000 3:1 d:p weight ratio 20000 15000 10000 10000 50 100 150 200 250 Polymer 20000 Drug 15000 10000 0 0 0 Silicon 25000 5000 5000 0 30000 0 50 Depth (nm) 100 150 Depth (nm) 200 250 0 50 100 150 Depth (nm) • The drug migrates to both the surface and the interface (film/silicon) • The polymer is concentrated in the bulk region. • Relative ion peak intensities for drug and polymer markers are consistent with the respective concentration 84 Sputter time (sec) 115 Sputter rate (nm/sec) 0.81 1:1 d:p wr 93 93 1 3:1 d:p wr 83 95 0.87 Sample ID Thickness (nm) 1:3 d:p wr 200 250 Results. AFM characterization Globular features Peak force QNM mode Series 3. 1:1 drug polymer wr 185 nm Topography Series 2. 1:1 drug polymer wr Topography a Deformation DMT modulus 3.5 GPa 1 1 µm 0 nm a 1µm Diameters: ≈ 100 nm 1.5 x 1.5 µm 2 x 2 µm 1 230 MPa b b 2 x 2 µm Series 3. 1:3 drug polymer wr Diameters: ≈ 200 nm Topography 216 nm 1µm 1 GPa 1 µm 0 nm 1.5 x 1.5 µm Series 2. 2 areas of spun cast film at 1:1 drug polymer weight ratio. Globular features with a diameters of approximately 100200 nm can be observed. Their formations is probably due to the dry step at 50°C for 45 min. 2 2 DMT modulus 75 MPa Series 3. Granular structure of the domain. The size of the globular structure varies between 100 and 200 nm.
Similar documents
Approaches to IVIVC Development for Regulatory Success
“Type II variations - pharmaceutical” 63 licenses of interest
More information